Comerica Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$338K Sell
4,878
-340
-7% -$23.6K 0.03% 335
2023
Q2
$492K Sell
5,218
-670
-11% -$63.2K 0.03% 301
2023
Q1
$487K Buy
5,888
+80
+1% +$6.62K 0.04% 300
2022
Q4
$433K Buy
+5,808
New +$433K 0.03% 322
2022
Q1
Sell
-7,328
Closed -$949K 499
2021
Q4
$949K Buy
7,328
+293
+4% +$37.9K 0.06% 245
2021
Q3
$796K Buy
+7,035
New +$796K 0.06% 269
2021
Q2
Sell
-5,752
Closed -$481K 484
2021
Q1
$481K Buy
5,752
+660
+13% +$55.2K 0.04% 325
2020
Q4
$465K Buy
5,092
+1,516
+42% +$138K 0.04% 308
2020
Q3
$285K Buy
3,576
+569
+19% +$45.3K 0.03% 351
2020
Q2
$208K Buy
+3,007
New +$208K 0.02% 410
2019
Q4
Sell
-5,220
Closed -$383K 447
2019
Q3
$383K Sell
5,220
-8,139
-61% -$597K 0.04% 317
2019
Q2
$823K Sell
13,359
-1,062
-7% -$65.4K 0.09% 212
2019
Q1
$920K Buy
14,421
+72
+0.5% +$4.59K 0.1% 198
2018
Q4
$733K Sell
14,349
-672
-4% -$34.3K 0.1% 204
2018
Q3
$872K Sell
15,021
-3,711
-20% -$215K 0.1% 209
2018
Q2
$909K Sell
18,732
-609
-3% -$29.6K 0.11% 207
2018
Q1
$899K Sell
19,341
-120
-0.6% -$5.58K 0.11% 206
2017
Q4
$731K Buy
19,461
+6,303
+48% +$237K 0.09% 228
2017
Q3
$479K Buy
13,158
+3,270
+33% +$119K 0.07% 257
2017
Q2
$390K Sell
9,888
-285
-3% -$11.2K 0.06% 279
2017
Q1
$319K Buy
+10,173
New +$319K 0.05% 302
2016
Q3
Sell
-6,723
Closed -$223K 226
2016
Q2
$223K Sell
6,723
-1,557
-19% -$51.6K 0.11% 182
2016
Q1
$243K Buy
+8,280
New +$243K 0.13% 162